Finance Archives

26 Mar Payment of Retention Fees for the Year Ending 31 December 2026

Posted at 08:28h in

The Medicines and Related Substances Act No. 101 of 1965 as amended makes provisions for the payment of retention fees to the South African Health Products Regulatory Authority (SAHPRA) in respect of medicines registered, medical devices, including in vitro diagnostics (IVDs), establishment licences issued. These...

02 Apr Payment of Retention Fees for the Year Ending 31 December 2025

Posted at 08:50h in

Your attention is drawn to the provisions of the Medicines and Related Substances Act, 101 of 1965, as amended, which provide for the payment of retention fees to the South African Health Products Regulatory Authority (SAHPRA) in respect of medicines registered and medical devices, including...

12 Feb Newly Gazetted Regulation Regarding Fees Payable in Terms of the Medicines and Related Substances Act

Posted at 18:52h in

This document is intended to provide communication to updated Regulations Regarding Fees Payable in Terms of the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965) have been gazetted on 12 February 2025 introducing a new fee dispensation....

07 Feb Revised Fees Regulation Update

Posted at 17:04h in

This document is intended to provide communication on the revised Regulation Regarding Fees Payable in Terms of the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965)....

22 Nov Submission Dates for Claims

Posted at 15:25h in

Attn: Board/Committee Members/Evaluators: Please take note of the dates for submission of claims for the remainder of the 2024/25 financial year....

02 May Clinical Variations Fee Schedule and Explanatory Notes

Posted at 14:41h in

02 May Explanatory Note on Fees Payable for Technical Amendments Related to Quality

Posted at 14:37h in

The SAHPRA fees that have been gazetted are implementable from 22 December 2020. The fees outlined in most cases are self-explanatory, however in the case of fees payable for technical amendments related to quality, there are several options listed which require clarity and hence the...

02 May Annual retention fee payment notification for year ending 31 December 2024

Posted at 14:30h in

Payment of retention fees for the year ending 31 March 2024 in respect of medicines and/or various licences registered until 31 December 2023....

02 May Annual retention fee payment notification for the Financial year ending 31 March 2020

Posted at 14:29h in

Your attention is drawn to the provisions of the Medicines and Related Substances Act, 1965 (Act 101 of 1965) as amended, making provision for the payment of retention fees to the Regulatory Authority in respect of medicines, medical devices and IVDs registered and site licences...

02 May Annual retention fee payment notification for the Financial year ending 31 March 2022

Posted at 14:24h in

Payment of Retention Fees for the Financial Year Ending 31 March 2022 in Respect of Medicines Registered Up and Until 31 December 2020 and/or Manufacture or Wholesale Licences...

Archive